NEUROPLAST
ActiveSummary
NEUROPLAST has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €199,460 and a net result of -€231. Equity is growing by ~41% per year across the filed fiscal years. Its solvency ranks better than 16% of 2372 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability45▼-5
Solvency37▼-6
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €11,000 at 30 days acceptable
Liquidity short (current ratio 0.29 against 2.13 in 2024; short-term debt: 31% and cash: 1% of total assets), and 87.5% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 16% of 2372 sector peers (2025).
NBB · sector comparisonPosition among 2372 sector peers
Solvency
better than 16%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
29 d early
2024
30 d early
2023
29 d early
2022
28 d early
2021
31 d early
2020
17 d early
2019
30 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 28 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 2 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€231
2024 · €33,104
Working capital
-€353,855
2024 · €151,490
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€114,307€75,454▼ 34.0%€106,991▲ 41.8%€90,061▼ 15.8%€56,634▼ 37.1%
Net result€96,000within the sector's middle half€66,263within the sector's middle half▼ 31.0%€57,421within the sector's middle half▼ 13.3%€33,104within the sector's middle half▼ 42.3%-€231below the sector's middle half
Equity€42,902below the sector's middle half€109,165within the sector's middle half▲ 154%€166,586within the sector's middle half▲ 52.6%€199,690within the sector's middle half▲ 19.9%€199,460within the sector's middle half▼ 0.1%
Total assets€202,206below the sector's middle half▲ 84.5%€245,803below the sector's middle half▲ 21.6%€660,140within the sector's middle half▲ 169%€1.1mwithin the sector's middle half▲ 67.4%€1.6mwithin the sector's middle half▲ 44.8%
Debt€159,304▼ 2.1%€136,638▼ 14.2%€493,554▲ 261%€905,253▲ 83.4%€1.4m▲ 54.7%
Working capital€149,822within the sector's middle half▲ 110%€197,372within the sector's middle half▲ 31.7%€246,666within the sector's middle half▲ 25.0%€151,490within the sector's middle half▼ 38.6%-€353,855below the sector's middle half
Solvency21.2%below the sector's middle half▲ 69.7pp44.4%within the sector's middle half▲ 23.2pp25.2%within the sector's middle half▼ 19.2pp18.1%below the sector's middle half▼ 7.2pp12.5%below the sector's middle half▼ 5.6pp
Current ratio4.98within the sector's middle half▲ 0.706.68above the sector's middle half▲ 1.704.04within the sector's middle half▼ 2.642.13within the sector's middle half▼ 1.910.29below the sector's middle half▼ 1.85
Return on assets (ROA)47.5%above the sector's middle half▲ 103.9pp27.0%above the sector's middle half▼ 20.5pp8.7%within the sector's middle half▼ 18.3pp3.0%below the sector's middle half▼ 5.7pp0.0%below the sector's middle half▼ 3.0pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 37% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.6m
Fixed assets
€1.5m ▲ 77.8%
Current assets
€142,132 ▼ 50.2%
Equity and liabilities €1.6m
Equity
€199,460 ▼ 0.1%
Debt
€1.4m ▲ 54.7%
Debt's share of the balance-sheet total rises from 81.9% to 87.5%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€166,471▲
2024 · €127,527
Cash flow
€109,606▲
2024 · €70,571
Debt to equity
7.02▲
2024 · 4.53
ROE
-0.1%▼
2024 · 16.6%
Interest coverage
3.11▼
2024 · 3.32
Debt ≤ 1 year
€495,987▲
2024 · €133,750
Debt > 1 year
€902,147▲
2024 · €769,314
Income taxes
€3,339▼
2024 · €18,573
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 1,423 companies that looked in July 2024 the way this one looks now, 1.0% went bankrupt within 24 months and 96% are still going.
- Small
- 10 to 20 years old
- solvency 10 to 30%
- a small loss
1.0%
went bankrupt
2.2%
stopped otherwise
96%
still going
A further 0.4% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 1,423 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €6,184 | €5,483 | €9,917 | €37,466 | €109,837 | ▲ 193% |
| Other operating charges640/8 | €626 | €576 | €1,116 | €1,974 | €2,013 | ▲ 2.0% |
| Gross operating margin9900 | €121,117 | €81,513 | €118,024 | €129,501 | €168,484 | ▲ 30.1% |
| Operating profit (loss)9901 | €114,307 | €75,454 | €106,991 | €90,061 | €56,634 | ▼ 37.1% |
| Financial income75/76B | €4,331 | €6,083 | - | - | - | - |
| Recurring financial income75 | €4,331 | €6,083 | - | - | - | - |
| Financial charges65/66B | €7,743 | €6,509 | €14,517 | €38,383 | €53,526 | ▲ 39.5% |
| Recurring financial charges65 | €7,743 | €6,509 | €14,517 | €38,383 | €53,526 | ▲ 39.5% |
| Profit (loss) for the period before taxes9903 | €110,895 | €75,028 | €92,474 | €51,677 | €3,108 | ▼ 94.0% |
| Income taxes67/77 | €14,895 | €8,765 | €35,053 | €18,573 | €3,339 | ▼ 82.0% |
| Profit (loss) for the period9904 | €96,000 | €66,263 | €57,421 | €33,104 | -€231 | ▼ 101% |
| Profit (loss) for the period to be appropriated9905 | €96,000 | €66,263 | €57,421 | €33,104 | -€231 | ▼ 101% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €202,206 | €245,803 | €660,140 | €1.1m | €1.6m | ▲ 44.8% |
| Fixed assets21/28 | €14,784 | €13,697 | €332,299 | €819,703 | €1.5m | ▲ 77.8% |
| Intangible fixed assets21 | - | €0 | - | - | - | - |
| Tangible fixed assets22/27 | €14,784 | €13,697 | €332,299 | €812,703 | €1.5m | ▲ 78.5% |
| Land and buildings22 | - | - | €323,667 | €793,914 | €1.4m | ▲ 80.7% |
| Plant, machinery and equipment23 | €3,208 | €2,838 | €2,469 | €2,099 | €1,729 | ▼ 17.6% |
| Furniture and vehicles24 | €11,576 | €10,859 | €6,164 | €16,690 | €14,437 | ▼ 13.5% |
| Financial fixed assets28 | - | - | - | €7,000 | €7,000 | = |
| Current assets29/58 | €187,422 | €232,106 | €327,841 | €285,240 | €142,132 | ▼ 50.2% |
| Amounts receivable after more than one year29 | - | - | €125,000 | - | - | - |
| Other amounts receivable291 | - | - | €125,000 | - | - | - |
| Amounts receivable within one year40/41 | €124,292 | €176,075 | €126,259 | €109,776 | €121,714 | ▲ 10.9% |
| Trade receivables40 | €53,128 | €70,800 | €85,259 | €94,476 | €96,714 | ▲ 2.4% |
| Other amounts receivable41 | €71,164 | €105,275 | €41,000 | €15,300 | €25,000 | ▲ 63.4% |
| Cash at bank and in hand54/58 | €63,130 | €56,031 | €76,582 | €174,135 | €15,849 | ▼ 90.9% |
| Deferred charges and accrued income490/1 | - | - | - | €1,329 | €4,569 | ▲ 244% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €202,206 | €245,803 | €660,140 | €1.1m | €1.6m | ▲ 44.8% |
| Equity10/15 | €42,902 | €109,165 | €166,586 | €199,690 | €199,460 | ▼ 0.1% |
| Contributions10/11 | €6,200 | €6,200 | €8,060 | €8,060 | €8,060 | = |
| Capital10 | €6,200 | €6,200 | - | - | - | - |
| Issued capital100 | €18,600 | €18,600 | - | - | - | - |
| Uncalled capital101 | €12,400 | €12,400 | - | - | - | - |
| Reserves13 | €1,860 | €1,860 | €57,421 | €90,525 | €90,525 | = |
| Non-distributable reserves130/1 | €1,860 | €1,860 | - | - | - | - |
| Legal reserve130 | €1,860 | €1,860 | - | - | - | - |
| Distributable reserves133 | - | - | €57,421 | €90,525 | €90,525 | = |
| Profit (loss) carried forward14 | €34,842 | €101,105 | €101,105 | €101,105 | €100,875 | ▼ 0.2% |
| Amounts payable17/49 | €159,304 | €136,638 | €493,554 | €905,253 | €1.4m | ▲ 54.7% |
| Amounts payable after more than one year17 | €121,704 | €101,905 | €412,379 | €769,314 | €902,147 | ▲ 17.3% |
| Financial debts170/4 | €121,704 | €101,905 | €412,379 | €769,314 | €902,147 | ▲ 17.3% |
| Amounts payable within one year42/48 | €37,600 | €34,734 | €81,175 | €133,750 | €495,987 | ▲ 271% |
| Current portion of amounts payable after more than one year42 | €19,260 | €19,800 | €23,539 | €45,464 | €61,200 | ▲ 34.6% |
| Financial debts43 | - | - | €28,000 | €8,045 | - | - |
| Credit institutions430/8 | - | - | €28,000 | €8,045 | - | - |
| Trade debts44 | €10,688 | €6,674 | €10,190 | €36,254 | €16,684 | ▼ 54.0% |
| Suppliers440/4 | €10,688 | €6,674 | €10,190 | €36,254 | €16,684 | ▼ 54.0% |
| Taxes, remuneration and social security45 | €7,652 | €8,260 | €17,205 | €25,014 | €35,248 | ▲ 40.9% |
| Taxes450/3 | €7,652 | €8,260 | €9,369 | €16,915 | €20,999 | ▲ 24.1% |
| Remuneration and social security454/9 | - | - | €7,836 | €8,100 | €14,249 | ▲ 75.9% |
| Other amounts payable47/48 | - | - | €2,241 | €18,973 | €382,855 | ▲ 1,918% |
| Accrued charges and deferred income492/3 | - | - | - | €2,189 | €2,109 | ▼ 3.7% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €96,000 | €66,263 | €57,421 | €33,104 | -€231 | ▼ 101% |
| + Depreciation and write-downs630 | €6,184 | €5,483 | €9,917 | €37,466 | €109,837 | ▲ 193% |
| Operating cash flow (approximation) | €102,184 | €71,746 | €67,338 | €70,571 | €109,606 | ▲ 55.3% |
| Investment in fixed assets (approximation) | - | -€4,396 | -€328,519 | -€524,870 | -€747,704 | ▼ 42.5% |
| Change in cash | - | -€7,099 | €20,551 | €97,554 | -€158,286 | ▼ 262% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
02-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
01-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
02-07
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial
Equity above €150,000Eq €166,586 ▲52.6%
3 profitable years in a row build equity to €166,586.
03-07
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial
Equity above €100,000Eq €109,165 ▲154%
2 profitable years in a row build equity to €109,165.
30-06
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial
Back to profitnet €96,000
Net result €96,000 after one loss-making year.
14-07
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial
Weakest financial yearnet -€61,820
Net result drops to -€61,820, the lowest in the series; recovery starts the following year.
01-07
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
31-12
Financial
Back to profitnet €36,658
Net result €36,658 after one loss-making year.
Show earlier events
10-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
24-07
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
25-07
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Mons · 1 establishment unit since 2008
Ground area
4,050 m²
Building footprint
119 m²
Volume, LiDAR
743 m³
Parcel 53404B0328/00S003, Wallonia · tallest building 7.8 m, ±2 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
NEUROPLAST
since 20082.191.054.509
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 53404B0328/00S003 | Wallonia | 4,050 m² | 1 · 119 m² | 7.8 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
2 ownersOwners 2
- Florian Gaedenatural personSourceown accounts 202150%
- Patricia Rodondo Saeznatural personSourceown accounts 202150%
Holdings 0
The accounts to 31-12-2021 list no holdings, and no other source names one.
According to the 2021 annual accounts of NEUROPLAST and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Similar companies · same sector, comparable size
CABINET DE DIAGNOSTIC RADIOLOGIQUE ET ECHOGRAPHIQUE
BE 0433.328.989
Pont-à-Celles · Eq €199,370
YVOMEDICAL
BE 0747.944.036
Brussel · Eq €199,253
DOCTEUR BOTTIN-SCHOENEN
BE 0895.492.716
Chaudfontaine · Eq €199,755
Dr. M. Denis
BE 0805.034.672
Mortsel · Eq €199,825
JMedInvest
BE 0671.921.671
Zaventem · Eq €199,004
Of 16,629 companies in sector 86220 we hold annual accounts for 7,986. 6,746 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded21-11-2008
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0807910723
Registered
14-11-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.